American Lung Association calls for urgent universal COVID-19 antibody testing

American Lung Association calls for urgent universal COVID-19 antibody testing

The COVID-19 pandemic has resulted in unprecedented rates of lung infections and deaths in modern history. To save lives and decrease the risk of a generation of survivors with severely damaged lung health, the American Lung Association is calling for the urgent nationwide rollout of coordinated and universal COVID-19 antibody testing. The lives of too many have been lost, especially those most vulnerable – the elderly, chronically ill and minority populations. Unfortunately, in addition to the deaths, we may face a generation of those who have recovered from COVID-19, but are permanently burdened with damaged lung health that will affect their productivity, quality of life and likely their longevity. To reduce the spread, our nation must act urgently to implement both antibody testing to identify immune individuals and nasal swab tests to identify current infections, in tandem.” Harold Wimmer, American Lung Association President and CEO The more people you can test - both for current infections and the antibodies created by prior infections - the more accurately you can determine who’s safe from the virus and who’s spreading it to others. This containment effort becomes even more important as mitigation efforts such as social distancing are relaxed. The more you can do that, the more everyone can isolate and stop spreading the virus further to save lives and decrease the post-COVID-19 risk of chronic lung disease.” Albert Rizzo, M.D., American Lung Association Chief Medical Officer Related Stories



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More